Stallergenes Greer, a global leader in allergy therapeutics, announced today that its Phase IIIb clinical study (YOBI, YOung patients and BIrch allergy), designed to confirm the safety and efficacy of ...
LOS ALTOS, Calif., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics (UNCY), Inc. , a clinical-stage biotechnology company developing therapies for patients with kidney disease (the “Company” ...
n = number of patients included in each study group for safety and tolerability assessments Abbreviations: EOS: End of Study (week 16); BID: twice daily; CBD: cannabidiol; QD: once daily. Of the DHT ...
THE WOODLANDS, Texas, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the completion of patient enrollment in the PROGRESS (A Phase 2b, Dose-ranging, ...
Want to have successful IVF? If you're an older woman, find some donor eggs. Most successful fertility treatments for women 43 and older rely on donor eggs, researchers report in the journal ...
Once excite- Case Study: Successful Joint-Venture Turnaround By Renée Tomcanin 28 visit www.beckersasc.comment grew, the proposed changes were adapted with the backing of everyone on staff, making for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results